Diagnosis and treatment of cervical cancer: barriers faced by women during the Covid-19 Pandemic
DOI:
https://doi.org/10.15343/0104-7809.202448e16502024PKeywords:
Uterine Cervical Neoplasms, Women's Health, Therapeutic Itinerary, COVID-19, NursingAbstract
The objective of this study was to understand the healthcare experiences and barriers faced by women with cervical cancer during the COVID-19 pandemic. This is an exploratory, qualitative, and multiple-case study research. Nine women with cervical cancer participated, and the content analysis technique was used. The different care trajectories within health services and the search for cancer diagnosis and treatment were evident. In all trajectories mentioned, there was no call for a cytopathological examination of the cervix. One of the outstanding aspects was the time between diagnosis and the start of treatment, which varied from 15 to 150 days among the women. Considering the trajectories uniquely in the health care system, those were different during the COVID-19 pandemic. Some barriers made it problematic to control and treat cancer. This study allows the understanding of trajectories and practices in the different logics expressed, through which the principles of comprehensiveness and resolution in health can be questioned. Thus, it supports an evaluative practice in health that privileges the experience of health or illness, as well as users’ seeking for care.
Downloads
References
Cesar JA, Souto AM, Lelis CD, Pinheiro LP, Dutra RP, Terlan RJ. Citopatológico de colo uterino no extremo sul do Brasil: baixa cobertura e exposição das gestantes mais vulneráveis. Rev. Bras. Epidemiol [Internet], 2023 (accessed 02 November 2024); 26: e230032. DOI: 10/1590/1980-549720230032.2
da Mata S, Ferreira J, Nicolás I, Esteves S, Esteves G, Lérias S, et al. P16 and HPV genotype significance in HPV-associated cervical cancer—a large cohort of two tertiary referral centers. Int. J. Mol. Sci [Internet], 2021 (accessed 02 November 2024); 22(5): 1-14. DOI: 10.3390/ijms22052294
da Silva Júnior JA, Oliveira Bezerra LL, Gomes da Silva Freitas JL, Pessoa dos Santos SM, Pinheiro Fernandes de Queiroga R, de Freitas Silva TR. The knowledge of nursing students about cervical cancer. Rev. Enferm. UFSM [Internet], 2021 (accessed 02 November 2024); 11(e7): 1-18. DOI: 10.5902/2179769241938
Keane A, Ng CW, Simms KT, Nguyen D, Woo YL, Saville M, et al. The road to cervical cancer elimination in Malaysia: evaluation of the impact and cost‐effectiveness of human papillomavirus screening with self‐collection and digital registry support. Int. J. Cancer [Internet], 2021 (accessed 02 November 2024); 149(12): 1997-2009. DOI: 10.1002/ijc.33759
Ginsburg O, Basu P, Kapambwe S, Canfell K. Eliminating cervical cancer in the COVID-19 era. Nat. Cancer [Internet], 2021 (accessed 02 November 2024); 2(2): 133-134. DOI: 10.1038/s43018-021-00178-9
Sim J, Shin J, Lee HJ, Lee Y, Kim YA. Impact of coronavirus disease 2019 on cancer care: How the pandemic has changed cancer utilization and expenditures. Plos one [Internet], 2024 (accessed 02 November 2024); 19(2): e0296808. DOI: 10.1371/journal. pone.0296808
Jazieh AR, Akbulut H, Curigliano G, Rogado A, Alsharm AA, Razis ED, et al. Impact of the COVID-19 pandemic on cancer care: a global collaborative study. JCO Glob. Oncol. [Internet], 2020 (accessed 02 November 2024); 6: 1428-1438. DOI: 10.1200/GO.20.00351
Kaufmann LC, França AF, Zilly A, Ferreira H, Silva RM. Repercussions of the COVID-19 pandemic on cervical cancer screening: nurses’ perception. Esc. Anna Nery [Internet], 2023 (accessed 02 November 2024); 27: e20220401. DOI: 10.1590/2177-9465-EAN 2022-0401pt
Silva LF, Cursino EG, Brandão ED, Góes FG, Depiant JR, Silva LJ, et al. The therapeutic itinerary of health workers diagnosed with COVID-19. Rev. Lat. Am. Enfermagem [Internet], 2021 (accessed 02 November 2024); 29: 1-10. DOI: 10.1590/1518-8345.4691.3413
Yin RK. Pesquisa qualitativa do início ao fim. Penso Editora; 2016.
Creswell JW, Creswell JD. Projeto de pesquisa: Métodos qualitativo, quantitativo e misto. Penso Editora; 2021.
Gao XS, Boere IA, van Beekhuizen HJ, Franckena M, Nout R, Kruip MJ, et al. Acute and long-term toxicity in patients undergoing induction chemotherapy followed by thermoradiotherapy for advanced cervical cancer. Int. J. Hyperthermia [Internet], 2022 (accessed 02 November 2024); 39(1): 1440-1448. DOI: 10.1080/02656736.2022.2146213
Sardinha AH, Verzaro PM, Rolim NC, Sousa SM, Silva AP, Lopes AR. Association between demographic variables and cervical cancer staging in elderly women: a retrospective study. Online Braz. J. Nurs. [Internet], 2021 (accessed 02 November 2024); 20: e20216479. DOI: 10.17665/1676-4285.20216479
De Sousa ML, Cantinho KM, de Alencar LN, Andrade IL, Costa LM, Barbosa SM, et al. Câncer de colo do útero: sinais e sintomas na Atenção Primária à Saúde. Res. Soc. Dev. [Internet], 2022 (accessed 02 November 2024); 11(13): e591111335891-. DOI: 10.33448/ rsd-v11i13.35891
de Farias KF, Gomes ML, da Silva DM, de Moura EL, dos Santos AC, da Silva AF, et al. Gynecological and obstetric profile of users who perform the Pap smear. Rev. Enferm. Atenção Saúde [Internet], 2023 (accessed 02 November 2024); 12(2): e202382. DOI: 10.18554/reas.v12i2.5998
Somanna SN, Murthy SN, Cheluvarayaswamy R, Malila N. Time from self-detection of symptoms to seeking definitive care among cervical cancer patients. Asian Pac. J. Cancer Prev. [Internet], 2020 (accessed 02 November 2024); 21(11): 3301-3307. DOI: 10.31557/ APJCP.2020.21.11.3301
Galvão JR, Almeida PF, Santos AM, Bousquat A. Percursos e obstáculos na Rede de Atenção à Saúde: trajetórias assistenciais de mulheres em região de saúde do Nordeste brasileiro. Cad. Saúde Pública [Internet], 2019 (accessed 02 November 2024); 35(12): e00004119. DOI: 10.1590/0102-31100004119
Madeiro A, Rufino AC. Cobertura e fatores associados à não realização do exame citopatológico do colo do útero entre mulheres brasileiras de 18 a 39 anos. J. Health Biol. Sci. [Internet], 2022 (accessed 02 November 2024); 10(1): 1-9. DOI: 10.12662/2317- 3206jhbs.v10i1.3521.p1-9.2022
Moreira DP, Santos MA, Pilecco FB, Dumont-Pena É, Reis IA, Cherchiglia ML. Tratamento ambulatorial do câncer do colo do útero em tempo oportuno: a influência da região de residência de mulheres no Estado de Minas Gerais, Brasil. Cad. Saúde Pública [Internet], 2022 (accessed 02 November 2024); 38(10): e00277521. DOI: 10.1590/0102-311XPT277521
Lopes VA. Acesso e continuidade assistencial na atenção ao câncer de colo de útero. Soc. Debate [Internet], 2021 (accessed 02 November 2024); 27(2): 231-243. DOI: 10.47208/sd.v27i2.2901.
Lopes VA, Ribeiro JM. Cervical cancer control limiting factors and facilitators: a literature review. Cien. Saude Colet. [Internet], 2019 (accessed 02 November 2024); 24(9): 3431-3442. DOI: 10.1590/1413-81232018249.32592017
Silva DS, Pinto MC, Figueiredo MA. Factors associated with delay in specialized treatment after diagnosis of cervical cancer in Bahia State, Brazil. Cad. Saúde Pública [Internet], 2022 (accessed 02 November 2024); 38(5): e00022421. DOI: 10.1590/0102- 311XPT022421
Doubova SV, Arsenault C, Contreras-Sanchez SE, Borrayo-Sanchez G, Leslie HH. The road to recovery: an interrupted time series analysis of policy intervention to restore essential health services in Mexico during the COVID-19 pandemic. J. Glob. Health [Internet], 2022 (accessed 02 November 2024); 12 :05033. DOI: 10.7189/jogh.12.05033
Duarte MB, Argenton JL, Carvalheira JB. Impact of COVID-19 in cervical and breast cancer screening and systemic treatment in São Paulo, Brazil: an interrupted time series analysis. JCO Glob. Oncol. [Internet], 2022 (accessed 02 November 2024); 8: e2100371. DOI: 10.1200/GO.21.00371
Vieira YP, Viero VD, Vargas BL, Nunes GO, Machado KP, Neves RG, et al. Tendência e desigualdades no rastreamento autorrelatado do câncer de colo de útero nas capitais brasileiras entre 2011 e 2020. Cad. Saúde Pública [Internet], 2022 (accessed 02 November 2024); 38(9): e00272921. DOI: 10.1590/0102-311XPT272921
Poniewierza P, Panek G. Cervical Cancer Prevention in the era of the COVID-19 pandemic. Medicina [Internet], 2022 (accessed 02 November 2024); 58(6): 732. DOI: 10.3390/medicina58060732
Cuadrado C, Vidal F, Pacheco J, Flores-Alvarado S. Acceso a la atención del cáncer en los grupos vulnerables de Chile durante la pandemia de COVID-19. Rev. Panam. Salud Publica [Internet], 2023 (accessed 02 November 2024); 46: 1-11. DOI: 10.26633/ RPSP.2022.77.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 O Mundo da Saúde
This work is licensed under a Creative Commons Attribution 4.0 International License.